HIMS
Hims & Hers Health, Inc.
There isn't enough reported data to score HIMS yet.
LUCY
Innovative Eyewear, Inc.
There isn't enough reported data to score LUCY yet.
HIMS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Stable | |
| Strong |
HIMS's revenue and balance sheet are currently strong, and its cash flow is stable, but its profitability is weak.
LUCY Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Weak | |
| Unavailable |
LUCY's revenue is currently strong, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
HIMS PE Valuation
HIMS has no meaningful PE right now: it lost money over the past year.
LUCY PE Valuation
LUCY has no meaningful PE right now: it lost money over the past year.
HIMS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect HIMS's revenue to grow, but its earnings to decline. However, they disagree widely on these estimates.
LUCY Forward outlook
There aren't enough analyst estimates for LUCY to show an outlook.
HIMS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.83 | -257% |
| Q2 2026 | -$0.63 | -180% |
| Q1 2026 | -$0.09 | -113% |
| Q4 2025 | $0.51 | -3.8% |
| Q3 2025 | $0.53 | +20% |
| Q2 2025 | $0.79 | +888% |
| Q1 2025 | $0.68 | +$0.69 |
| Q4 2024 | $0.53 | +$0.64 |
HIMS has swung to a loss: it lost $0.83 per share over the past year, after a profit the year before.
LUCY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$1.04 | +$2.90 |
| Q2 2026 | -$1.15 | +$3.40 |
| Q1 2026 | -$1.55 | +$4.21 |
| Q4 2025 | -$1.90 | +$6.14 |
| Q3 2025 | -$3.94 | +$5.72 |
| Q2 2025 | -$4.55 | +$6.52 |
| Q1 2025 | -$5.76 | +$6.44 |
| Q4 2024 | -$8.04 | +$4.56 |
LUCY has the edge over HIMS on earnings, with more consistent year-over-year improvement.
HIMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $890.4M | +49% |
| Q2 2026 | $753.2M | +38% |
| Q1 2026 | $608.1M | +3.8% |
| Q4 2025 | $617.8M | +28% |
| Q3 2025 | $599M | +49% |
| Q2 2025 | $544.8M | +73% |
| Q1 2025 | $586M | +111% |
| Q4 2024 | $481.1M | +95% |
HIMS's revenue has grown year over year every quarter since late 2021: $890M last quarter, up 49% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -7.4% | -9.4 points |
| Q2 2026 | -13% | -18 points |
| Q1 2026 | -13% | -23 points |
| Q4 2025 | 1.5% | -2.4 points |
| Q3 2025 | 2% | -3.6 points |
| Q2 2025 | 4.9% | +1.4 points |
| Q1 2025 | 9.9% | +6.3 points |
| Q4 2024 | 3.9% | +4 points |
HIMS's operating margin was −7.4% last quarter, down 9.4 points from the same quarter a year ago.
LUCY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1M | +51% |
| Q2 2026 | $1M | +74% |
| Q1 2026 | $773.6K | +70% |
| Q4 2025 | $959.8K | +39% |
| Q3 2025 | $668.1K | +163% |
| Q2 2025 | $579.2K | +88% |
| Q1 2025 | $454.5K | +19% |
| Q4 2024 | $690.7K | +12% |
LUCY has the edge over HIMS on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q1 2022 | -503% | -319 points |
| Q4 2021 | -501% | +393 points |
| Q3 2021 | -638% | +452 points |
| Q2 2021 | -408% | +1115 points |
| Q1 2021 | -185% | +1338 points |
| Q4 2020 | -894% | N/A |
| Q3 2020 | -1090% | N/A |
| Q2 2020 | -1523% | N/A |
LUCY's operating margin was −503% last quarter, down 319 points from the same quarter a year ago.
HIMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26M | -67% |
| Q2 2026 | -$68.2M | +$1.3M |
| Q1 2026 | $53.1M | +5.9% |
| Q3 2025 | $79.3M | -7% |
| Q2 2025 | -$69.5M | -230% |
| Q1 2025 | $50.1M | +94% |
| Q3 2024 | $85.3M | +238% |
| Q2 2024 | $53.6M | +219% |
LUCY has the stronger cash trend. Its trailing FCF is down 74% versus its history, compared with HIMS at down 84%.
LUCY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2025 | -$1.4M | +$602.4K |
| Q3 2025 | -$1.5M | -$112.6K |
| Q2 2025 | -$2.1M | -$183.7K |
| Q1 2025 | -$2.4M | -$852K |
| Q4 2024 | -$2M | -$860K |
| Q3 2024 | -$1.4M | +$30K |
| Q2 2024 | -$1.9M | -$82.6K |
| Q1 2024 | -$1.5M | -$44.4K |
LUCY has burned cash in almost every quarter: −$7M over the past year, against −$7M the year before.
HIMS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.9% | +2.1M shares |
| 1 year | -6% | -14.9M shares |
| 3 years | +11% | +23.7M shares |
| 5 years | +17% | +33.8M shares |
HIMS has the edge over LUCY on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | $80.5M |
| Q3 2025 | $9.5M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $5M |
| Q3 2024 | $30M |
| Q2 2024 | $19.9M |
| Q1 2024 | $28.1M |
LUCY Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +31% | +2M shares |
| 1 year | +162% | +5.2M shares |
| 3 years | +1900% | +8M shares |
| 5 years | +3769% | +8.2M shares |
| Available history | +8365% | +8.3M shares |
LUCY has 8M diluted shares, up 162% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2022 | — |
| Q4 2021 | — |
| Q3 2021 | — |
| Q2 2021 | — |
| Q1 2021 | — |
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
HIMS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -5.9x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -7.3x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -2.8x | Net Cash |
| Q3 2024 | -2.9x | Net Cash |
| Q2 2024 | -5.5x | Net Cash |
HIMS has more cash than debt.
LUCY Net Leverage
LUCY's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
HIMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.0 | Neutral |
| Stochastic | 23.0 | Neutral |
HIMS's weekly RSI is 36 (neutral) and its Stochastic is 23 (neutral).
LUCY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 44.2 | Neutral |
| Stochastic | 24.7 | Neutral |
LUCY's weekly RSI is 44 (neutral) and its Stochastic is 25 (neutral).
HIMS PE vs Healthcare Sector
| Metric | HIMS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
HIMS has no meaningful PE right now: it lost money over the past year.
LUCY PE vs Healthcare Sector
LUCY has no meaningful PE right now: it lost money over the past year.
HIMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.3 | 28% below |
| 20 week MA | $29.2 | 32% below |
| 50 week MA | $27.7 | 29% below |
| 100 week MA | $35.9 | 45% below |
| 200 week MA | $24.4 | 19% below |
HIMS is in a downtrend: it's below all five of its weekly moving averages, and 19% below its 200-week average.
LUCY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.86 | 5.8% below |
| 20 week MA | $0.83 | 2.4% below |
| 50 week MA | $1.01 | 20% below |
| 100 week MA | $1.96 | 59% below |
| 200 week MA | $8.99 | 91% below |
LUCY is in a downtrend: it's below all five of its weekly moving averages, and 91% below its 200-week average.
HIMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.89 | $15.0 | +51% |
| 2021 | $15.0 | $6.65 | -56% |
| 2022 | $6.65 | $6.43 | -3.3% |
| 2023 | $6.43 | $8.90 | +38% |
| 2024 | $8.90 | $26.6 | +198% |
| 2025 | $26.6 | $34.3 | +29% |
| 2026 YTD | $34.3 | $19.7 | -42% |
HIMS's yearly returns have swung widely, from +198% in 2024 to −56% in 2021. It's down 42% so far in 2026.
LUCY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2022 | $96.0 | $15.5 | -84% |
| 2023 | $15.5 | $8.44 | -46% |
| 2024 | $8.44 | $5.02 | -41% |
| 2025 | $5.02 | $1.22 | -76% |
| 2026 YTD | $1.22 | $0.81 | -34% |
LUCY has the edge over HIMS on returns for 2026, with the stronger performance.